Skip to main content

Investor Rights Alert: Halper Sadeh LLP Reminds Investors That It Is Investigating Whether the Sale of These Companies Is Fair to Shareholders - LTXB, CZR, GHDX

NEW YORK, NY / ACCESSWIRE / August 1, 2019 / Halper Sadeh LLP, a global investor rights law firm, reminds investors that it is investigating the following companies:

LegacyTexas Financial Group, Inc. (NASDAQ: LTXB)

The investigation concerns whether LegacyTexas and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of LegacyTexas to Prosperity Bancshares, Inc. Pursuant to the proposed transaction, LegacyTexas shareholders will receive 0.5280 shares of Prosperity common stock and $6.28 in cash for each share of LegacyTexas. If you are a LegacyTexas shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/legacytexas-financial-group-inc-ltxb-prosperity-bank-merger-stock/.

Caesars Entertainment Corporation (NASDAQ: CZR)

The investigation concerns whether Caesars and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Caesars to Eldorado Resorts, Inc. for $8.40 per share in cash and 0.0899 shares of Eldorado common stock for each share of Caesars common stock. If you are a Caesars shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/caesars-entertainment-corporation-czr-merger-stock-eldorado/.

Genomic Health, Inc. (NASDAQ: GHDX)

The investigation concerns whether Genomic Health and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Genomic Health to Exact Sciences Corp. If you are a Genomic Health shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/genomic-health-inc-ghdx-merger-stock-exact-sciences/.

On behalf of shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/554253/Investor-Rights-Alert-Halper-Sadeh-LLP-Reminds-Investors-That-It-Is-Investigating-Whether-the-Sale-of-These-Companies-Is-Fair-to-Shareholders--LTXB-CZR-GHDX

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.